SOD1

SOD1

SOD1 Overview

Molecule Name
Superoxide dismutase
Synonyms
SOD1,Superoxide dismutase 1,hSod1
Drug Development Progress
Drugs in Clinical Trials13
Approved Drugs3
Highest Development StageApproved
Target Synonym
SOD1,Superoxide Dismutase 1,HSod1,Amyotrophic Lateral Sclerosis 1 (Adult),Epididymis Secretory Protein Li 44,Superoxide Dismutase [Cu-Zn],Cu/Zn Superoxide Dismutase,Indophenoloxidase A,SOD, Soluble,EC 1.15.1.1,HEL-S-44,IPOA,ALS1,SOD,ALS,Superoxide Dismutase,STAHP,EC:1.15.1.1,Superoxide Dismutase 1, Soluble,Superoxide Dismutase, Cystolic,Homodimer
Background
Superoxide dismutase [Cu-Zn] (SOD1) is also known as superoxide dismutase 1 (hSod1), an enzyme that in humans is encoded by the SOD1 gene, located on chromosome 21. SOD1 can bind copper and zinc ions and is one of three superoxide dismutases responsible for destroying free superoxide radicals in the body. The encoded isozyme (SOD1) is a soluble cytoplasmic and mitochondrial intermembrane space protein, acting as a homodimer to convert naturally occurring, but harmful, superoxide radicals to molecular oxygen and hydrogen peroxide. Furthermore, the mutations of SOD1 gene can result in a neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord.

SOD1 Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
OtaplimastatSP-8203 hydrochloride; SP8203 HCL; SP-8203Phase 3 ClinicalShin Poong Pharmaceutical Co Ltd
Ischemic Stroke
Details
Bis-choline tetrathiomolybdateATN-224; WTX-101; ALXN-1840Phase 2 ClinicalWilson Therapeutics
Hepatolenticular Degeneration; Melanoma; Multiple Myeloma; Prostatic Neoplasms
Details
Superoxide dismutase (Ube Industries)r-hSOD; FKU-871Phase 2 ClinicalAstellas Pharma Inc, Ube Industries Ltd
Diabetic Neuropathies; Myocardial Ischemia
Details
BMX-010BMX-010; MnTE-2-PyP; MnTE-2-PyP5+Phase 2 ClinicalDuke University
Acne Vulgaris; Dermatitis, Atopic; Psoriasis; Rosacea
Details
TempolMBM-02; OT-674; NSC-142784; MTS-02; MTS-10; MTS-01; APC-410; APC-400; REC-994; MBM-01; REC-0000994Phase 2 ClinicalMitos
Alopecia; Anus Neoplasms; Ataxia Telangiectasia; Cardiovascular Diseases; Coronavirus Disease 2019 (COVID-19); Drug-Related Side Effects and Adverse Reactions; Glioblastoma; Hemangioma, Cavernous, Central Nervous System; Mucositis; Ototoxicity; Prostatic Neoplasms
Details
Superoxide dismutase analogue (LTT Bio-Pharma)LT-1001; LT-0011; PC-SOD NE; PC-SOD; LT-1002Phase 2 ClinicalLTT Bio-Pharma Co Ltd
Colitis, Ulcerative; Idiopathic Pulmonary Fibrosis; Myocardial Infarction; Peripheral Nervous System Diseases; Respiratory Distress Syndrome, Adult; Stroke
Details
RAG-17RAG-17; RD-12500Phase 2 ClinicalRactigen Therapeutics (Nantong) Co Ltd
Amyotrophic Lateral Sclerosis
Details
ALN-SODALN-SODPhase 2 ClinicalAlnylam Pharmaceuticals Inc
Amyotrophic Lateral Sclerosis
Details
NI-005AP-101 (AL-S Pharma); NI-005Phase 2 ClinicalAl-S Pharma Ag
Amyotrophic Lateral Sclerosis
Details
APB-102APB-102; AMT-162Phase 2 ClinicalUniversity Of Massachusetts Medical School
Amyotrophic Lateral Sclerosis
Details
NAS150AEOL-10150; NAS150; NAS-150Phase 1 ClinicalAeolus Pharmaceuticals
Idiopathic Pulmonary Fibrosis; Lung Injury; Neoplasms; Supranuclear Palsy, Progressive
Details
INS-1202INS1202; INS-1202Phase 1 ClinicalInsmed
Amyotrophic Lateral Sclerosis
Details
[89Zr]Zr-DFO-AP-101Phase 1 ClinicalUniversité De Sherbrooke
Amyotrophic Lateral Sclerosis; Tooth Diseases
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
OrgoteinApprovedGt Biopharma IncOntoseinSpainRheumatic Diseases; Cystitis; Radiation Injuriesnull1996-01-01
Cystitis; Radiation Injuries; Rheumatic Diseases
Details
Cupric Sulfate/Manganese sulfate/Selenious acid/Zinc SulfateApprovedAmerican Regent IncMULTRYSUnited StatesDietary SupplementAmerican Regent Inc2020-07-02
Dietary Supplement
Details
Tofersen99mTc-MAG3-BIIB067; ISIS-333611; BIIB-067; SODr/h333611; ISIS-SOD1Rx; IONIS SOD1RxApprovedIonis Pharmaceuticals Inc, Ludwig Institute For Cancer ResearchQALSODY, Qalsody, 凯盛迪United StatesAmyotrophic Lateral SclerosisBiogen Ma Inc, Biogen Inc2023-04-25
Amyotrophic Lateral Sclerosis; Familial Amyotrophic Lateral Sclerosis
Details